Home/Filings/4/0001179110-20-004927
4//SEC Filing

GOLDSTEIN MICHAEL 4

Accession 0001179110-20-004927

CIK 0001477449other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:02 PM ET

Size

13.5 KB

Accession

0001179110-20-004927

Insider Transaction Report

Form 4
Period: 2020-04-16
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-04-161,7008,000 total
    Exercise: $16.64Exp: 2026-08-08Common Stock (1,700 underlying)
  • Sale

    Common Stock

    2020-04-16$165.93/sh918$152,32414,805 total
  • Exercise/Conversion

    Common Stock

    2020-04-16$8.71/sh+13,105$114,14514,023 total
  • Exercise/Conversion

    Common Stock

    2020-04-16$16.64/sh+1,700$28,28815,723 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-04-1613,1050 total
    Exercise: $8.71Exp: 2025-02-25Common Stock (13,105 underlying)
  • Sale

    Common Stock

    2020-04-16$169.13/sh14,805$2,503,9700 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020.
  • [F2]Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
  • [F4]The option vested in full on May 24, 2017.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001043027

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:02 PM ET
Size
13.5 KB